Continued strong growth

27 Apr 2023 08:00 CEST

STOCKHOLM - April 27th, 2023 - ContextVision, a medical technology software
company specializing in image processing and image analysis, today proudly
presents their Q1 Report for 2023.

The robust growth continues and in the first quarter of 2023 the company saw a
revenue of SEK 32.4 M (27.2), an increase of 19% and an EBITDA of SEK 13.1 M
(9.2) an increase of 42%.

"We are continuing to grow our core business significantly more than the growth
of the industry overall, which is in line with our strategic ambition," says
Gerald Pötzsch, CEO of ContextVision.

With the successful strategy of focusing on larger OEMs, the main growth is
resulting from those customers. In Q1 specifically, the Asia region stands for
the majority of the new contracts signed. Ultrasound continues to be the
strongest business segment globally. In parallel the X-ray portfolio with new
functionalities within the year, to further strengthen growth in this business
segment.

"We have a very well-functioning, growing, and profitable core business. As we
want the company to take the next leap, we have also started to investigate
several adjacent areas where we believe our technical competence can make a
significant impact. The future looks very bright," continues Pötzsch.

###

This information is subject to the disclosure requirements pursuant to Section 5
-12 of the Norwegian Securities Trading Act

For further information, please contact ContextVision's CEO, Gerald Pötzsch, at
+46 8 750 35 50 or gerald.potzsch@contextvision.com or
visit www.contextvision.com (https://www.globenewswire.com/Tracker?data=3MaQGqfS
t
sB_Z2n6YL96mk
-0dfygLw6oN4eKvMWXKupICwsDDzA5ube1toUXebPYzar4qnu3TeaXF33IVlLZ60EyMCEFEOWZap0EhV
S
qE-zUKei2pFNr5cBFltRYMNo6kn7oL7CJxcgVx-hYON67FOGIkP2rl4
-54NJMeD5MzrIVSQFWmgmZB085ANCWw_
-3WhU_QFycYwSw79n9hRO8bD7Hmgptb56Phn4abKPm1hKO_3dkThorqVpb9FHkE5KXb2U2zArc9gueaS
X
iPxhqyw==).

###

About ContextVision
ContextVision is a medical technology software company specialized in image
analysis and artificial intelligence. As the global market leader within image
enhancement, we are a trusted partner to leading manufacturers of ultrasound, X
-ray and MRI equipment around the world.

Our expertise is to develop powerful software products, based on proprietary
technology and artificial intelligence for image-based applications. Our cutting
-edge technology helps clinicians accurately interpret medical images, a crucial
foundation for better diagnosis and treatment.

The company, established in 1983, is based in Sweden with local representation
in the U.S., Japan, China and Korea. ContextVision is listed on the Oslo Stock
Exchange under the ticker CONTX.

More information:
Access the news on Oslo Bors NewsWeb site

588750_ContextVision_Financial_Report_Q1_2023.pdf